[앵커]
Pfizer’s vaccine with an optimal storage temperature of -70 degrees Celsius dropped to -92 degrees Celsius during transportation and returned to the United States as an obstacle to quarantine.
In the meantime, the US FDA has established a policy that it is possible to use the vaccine that remains in the bottle after the dose is administered.
This is Lee Yeo-jin.
[기자]
In the United States, where Pfizer’s COVID-19 vaccine is being vaccinated, the temperature of the box has dropped to -92 degrees Celsius.
Army General Gustav Ferna, chief operating officer of the U.S. Corona 19 vaccine development program “Ultra-Rapid Operation,” said in California and Alabama that some of the vaccine had dropped below the appropriate temperature and immediately returned.
He added that the CDC of the Centers for Disease Control and Prevention and the FDA of the Food and Drug Administration will reveal whether vaccines stored at unstable temperatures are safe.
Pfizer vaccines, which must be stored at -70 degrees Celsius, were expected to be difficult to transport and store in bulk.
[다린 제룽 / 의료기기·보건기술 프로그램 개발자 : 영하 70도의 초저온 유통체계는 더 큰 시험대가 될 수 있습니다.]
Pfizer, who said there was no problem with transportation by developing a special thermal box, is not giving an answer to the excessive temperature drop.
In the midst of this, local media reported that the U.S. has set guidelines so that the leftovers of vaccine bottles can be used to alleviate the vaccine supply shortage.
Originally, 5 doses per bottle of vaccine is an appropriate amount, but as a result of checking at a front-line pharmacy, it is actually possible to receive from 6 to 7 doses.
Typically, pharmaceutical companies inject a sufficient amount above the threshold for possible spills or spills.
The United States has entered into further negotiations with Pfizer due to a lack of initial vaccine supplies.
[앨버트 불라 / 화이자 CEO (지난 14일 CNBC 인터뷰) : 미국 정부는 우리에게 1억 회분을 추가로 요구했고 우리는 미국에 제공할 위치에 있습니다. 다만 시간이 문제인데요. 그중 상당수를 우리는 내년 3분기까지 제공할 수 있는데 미국은 2분기에 달라고 요구하고 있습니다.]
Using residual vaccine can be expected to increase vaccine supply by up to 40%.
However, the FDA has banned the use of a mixture of residues from different bottles, saying there is a potential for contamination.
This is YTN Lee Yeo-jin.
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
– .
